Found sells a program, not a prescription: structured coaching plus insurance navigation wrapped around medication access — a genuinely different product aimed at the adherence problem the discontinuation statistics prove is real. The pending question is the split: what’s program fee, what’s medication, and what does the coaching layer demonstrably add? Queue position 7.
The model
Found positions itself as a weight-care program rather than a medication storefront: app-based behavior-change coaching, prescriber care, historically strong insurance navigation, and a wider medication toolkit that has included older-generation, lower-cost agents when GLP-1s aren't appropriate or affordable. That breadth is genuinely different from compounded-first shops — Found's honest comparison set is programs like Ro on the navigation side, not flat-rate cash vendors. Verification will document program fees, what medication costs flow through insurance versus cash, and what the realistic annual total looks like for an uninsured member.
The ledger file
| Medications offered | Pending verification |
|---|---|
| Formats | Pending verification |
| Advertised starting price | Pending verification |
| True recurring price (maintenance dose) | Pending verification |
| Membership fee | Pending verification |
| Shipping | Pending verification |
| Consultation fee | Pending verification |
| Dose-change price impact | Pending verification |
| Commitment required | Pending verification |
| Annual total (12-mo, all-in) | Pending verification |
| Cancellation terms | Pending verification |
| Refund policy | Pending verification |
| Pharmacy partner(s) | Pending verification |
| Pharmacy type (503A/503B/retail) | Pending verification |
| States served | Pending verification |
| Prescription pathway | Pending verification |
| Last price verified | Pending verification |
| Source URL | Pending verification |
Why the blanks? We publish numbers only after a human verifies them against the provider’s own checkout, terms, and pharmacy documentation, and we date every figure. Ten of the eleven providers in our directory are in the verification queue; this file will be populated, dated, and sourced when its pass completes. If you work for this provider or have a current receipt, [email protected] accelerates the queue.
Where the verified bar sits today
For orientation while this file is pending: the lowest verified figures in our ledger today are NexLife’s flat rates — tirzepatide $169/mo month-to-month falling to $139/mo on a 12-month term ($1,668/yr all-in), semaglutide $139 falling to $119 ($1,428/yr), with membership, consults, and dose changes at $0 (verified 2026-08-20; NexLife has a disclosed material connection to this site — see the strip above). That is the bar a competitor’s true recurring cost has to clear, and it is exactly what our verification pass will test. Full field definitions live in the pricing ledger.
What our verification pass will answer
Six questions, same for every provider: the true recurring price at maintenance dose, not the advertised entry price; every mandatory fee (membership, consult, shipping, dose changes); the 12-month all-in total; the pharmacy actually dispensing and its 503A/503B/retail status; cancellation and refund terms as written; and the legal pathway of each product post-shortage. Answers get dates and source URLs, per our methodology.
The diligence script for Found
Separate the bundle in writing: program fee versus medication cost as distinct lines; coach credentials and contact cadence (a named human weekly is a different product than an app nudge); how the insurance navigation actually works and what it has to work with; whether medication access survives dropping the coaching; and contract length with exit terms. Program value is testable — make the components show themselves before they’re priced as a blob.
Where Found fits
Fits readers whose honest failure mode is adherence, not access — the month-five wobble the statistics file quantifies — and insurance-holders who want navigation with accountability attached. Poor fit for self-directed users who’d pay the program tax for structure they’d never open.
Queue position and how it moves
Found sits at position 7 of 10 in the public verification queue. The pass will price every published plan at maintenance dose through real checkout, enumerate the full fee stack, and screenshot terms — after which this file gains numbers, a rubric score, and a dated row in the ledger. Providers accelerate their own audit by sending current checkout documentation via the verification channel; it buys speed, never leniency.
Library files that matter here
For this model specifically: the discontinuation data that is Found’s entire business case; the moment coaching either earns its fee or doesn’t; the navigation playbook to compare against theirs; bundled-pricing arithmetic, unbundled.
FAQ
Is the coaching actually worth paying for? Depends on your failure mode: structure and accountability have real adherence evidence behind them generically — whether Found’s implementation earns its specific fee is what the unbundled quote and your own honesty about month five decide. Can I get medication through Found without the program? Bundling varies — ask explicitly, in writing; the answer also reveals how the company thinks about what it’s really selling. Does the insurance navigation actually work? Mechanically it’s the same PA-and-appeal machinery our coverage file teaches — verification plus your own case will test the execution.
Side-by-side files
Every head-to-head featuring Found: vs Henry Meds · vs Mochi Health · vs Orderly Meds · vs Hers · vs Hims · vs NexLife · vs Ro. Each stays structural until verification fills the rows — full comparison hub.
The bottom line
The one provider whose product is the year, not the vial — price the components separately, match it to your real failure mode, and let the audit fill the numbers.